Zdrowie i gospodarka · 14/09/2018

FDA Announces Draft Guidance for 510(k) Third-Party Review Program

The Food and Drug Administration (FDA) has released a draft guidance document outlining its approach to the 510(k) Third-Party Review Program, a process allowing third-party review organizations to assess medical devices, providing an alternative to FDA's review process for higher-risk devices.